Atiprimod (SKandF 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppresive in candida-infected mice

This publication has 34 references indexed in Scilit:

• Single-Organism Model of Host Defense against Infection: A Novel Immunotoxicologic Approach to Evaluate Immunomodulatory Drugs
  Toxicologic Pathology, 1997
• Disease‐modifying activity of SK&F 106615 in rat adjuvant‐induced arthritis. Multiparameter analysis of disease including magnetic resonance imaging and bone mineral density measurements
  Arthritis & Rheumatism, 1996
• Biochemical and Functional Analysis of Rat Bronchoalveolar Macrophages Containing Chemically Induced Phospholipid Inclusions
  Toxicology and Applied Pharmacology, 1995
• Kinetics of Chloroquine Uptake into Isolated Rat Hepatocytes
  Journal of Pharmaceutical Sciences, 1993
• Interleukin‐4 and interleukin‐10 inhibit nitric oxide‐dependent macrophage killing of Candida albicans
  European Journal of Immunology, 1993
• Prevention of Diabetes and Induction of Non-Specific Suppressor Cell Activity in the BB Rat by an Immunomodulatory Azaspirane, SK&F 106610
  Journal of Autoimmunity, 1993
• Effect of a Human Immunodeficiency Virus Protease Inhibitor on Human Monocyte Function
  AIDS Research and Human Retroviruses, 1992
• Antiarthritic and supressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents
  Journal of Medicinal Chemistry, 1990
• Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes
  International Journal of Immunopharmacology, 1989
• Experimental Disseminated Candidiasis. II, Administration of Glucocorticosteroids, Susceptibitity to Infection, and Immunity
  The Journal of Infectious Diseases, 1975